Latest publications
Targeted proteomics to assess the response to anti-angiogenic treatment in human glioblastoma (GBM).
- NORLUX Neuro-Oncology Laboratory
- Proteomics of Cellular Signaling
2016 Feb. Mol Cell Proteomics.15(2):481-92. Epub 2015 Aug 4.
Transmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.
- NORLUX Neuro-Oncology Laboratory
2016 Jan. Oncotarget.7(1):593-609. Epub 2015 nov 11.
Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
2015 Dec. Nat Cell Biol.17(12):1556-68. Epub 2015 Nov 23.
Intercellular transfer of transferrin receptor by a contact-, Rab8-dependent mechanism involving tunneling nanotubes.
- NORLUX Neuro-Oncology Laboratory
2015 Nov. FASEB J.29(11):4695-712. Epub 2015 Jul 28.
Correction: Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.
- NORLUX Neuro-Oncology Laboratory
2015 Oct. PLoS One.10(10):e0140303.
Melanoma brain metastasis is independent of lactate dehydrogenase A expression.
- NORLUX Neuro-Oncology Laboratory
2015 Oct. Neuro Oncol.17(10):1374-85. Epub 2015 Mar 19.
Engraftment of Human Glioblastoma Cells in Immunocompetent Rats through Acquired Immunosuppression.
- NORLUX Neuro-Oncology Laboratory
2015 Aug. PLoS One.10(8):e0136089.
The pH sensibility of actin-bundling LIM proteins is governed by the acidic properties of their C-terminal domain.
- Cytoskeleton and Cancer Progression
- NORLUX Neuro-Oncology Laboratory
- DNA Repair and Chemoresistance
2015 Aug. FEBS Lett.589(18):2312-9. Epub 2015 Jul 29.
Inference of low and high-grade glioma gene regulatory networks delineates the role of Rnd3 in establishing multiple hallmarks of cancer.
- NORLUX Neuro-Oncology Laboratory
2015 Jul. PLoS Genet.11(7):e1005325.
Gauging heterogeneity in primary versus recurrent glioblastoma.
- NORLUX Neuro-Oncology Laboratory
2015 Jul. Neuro Oncol.17(7):907-9. Epub 2015 May 12.
Effect of endogenous inhibitors of tyrosine kinase receptors on glioma growth: a role for LRIG1? (Doctoral thesis)
- NORLUX Neuro-Oncology Laboratory
2015 May. Luxembourg: Université de Luxembourg 2015. 149 p.
Comprehensive analysis of glycolytic enzymes as therapeutic targets in the treatment of glioblastoma.
- NORLUX Neuro-Oncology Laboratory
- Platform LUXGEN - Micro-Array
2015 May. PLoS One.10(5):e0123544.
OECI-EACR precision medicine for cancer: Conference report 1-4 March 2015, Luxembourg.
- NORLUX Neuro-Oncology Laboratory
2015 Apr. ecancermedicalscience.9:519.
Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.
- Computational Biomedicine
- NORLUX Neuro-Oncology Laboratory
2015 Mar. Cell Commun Signal.13(1):23.
Whole genomes redefine the mutational landscape of pancreatic cancer.
- NORLUX Neuro-Oncology Laboratory
2015 Feb. Nature.518(7540):495-501.
Towards the application of alginate cell microencapsulation technologies to treat brain tumors. (Doctoral thesis)
- NORLUX Neuro-Oncology Laboratory
2015 Feb. Groningen: University of Groningen, 2015. 154 p.
Axitinib increases the infiltration of immune cells and reduces the suppressive capacity of monocytic MDSCs in an intracranial mouse melanoma model.
- NORLUX Neuro-Oncology Laboratory
2015 Jan. OncoImmunology.4(4):e998107.
A gene mapping bottleneck in the translational route from zebrafish to human.
- NORLUX Neuro-Oncology Laboratory
2015 Jan. Front Genet.5:470.
Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
- NORLUX Neuro-Oncology Laboratory
- Translational Radiomics
2015 Jan. Acta Neuropathol.129(1):115-31. Epub 2014 Oct 17.
Multimodal imaging of physiologic changes induced by anti-angiogenic therapy in glioblastoma. (Doctoral thesis)
- NORLUX Neuro-Oncology Laboratory
2014 Dec. Bergen: University of Bergen, 2014. 56 (+ References) p.